Issue Date: August 11, 2014
Bristol-Myers Seeks Academic Access
Bristol-Myers Squibb has formed an alliance with Boston-based Allied Minds aimed at tapping research and preclinical drug development from U.S. universities. Eight-year-old Allied Minds works with 33 U.S. universities to form companies based on academia-invented technology. Under the agreement, BMS and Allied Minds have created Allied-Bristol Life Sciences to work with university researchers on forming drug discovery companies. BMS will have the option to acquire successful firms from Allied-Bristol.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society